|
Market Closed -
OTC Markets
01:20:56 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.007400 USD | -5.13% |
|
-3.90% | -22.11% |
| 15/08 | Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 01/07 | HUB Cyber Security Acquires Evofem Notes, Cuts Staff | MT |
| Market Cap | 10L 9L 8L 7L 13.74L 9.41Cr 13.8L 96.73L 37.33L 4.78Cr 36.84L 36.02L 15Cr | P/E 2024 |
-0.08x | P/E 2025 | 26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.54Cr 4.83Cr 4.56Cr 4.14Cr 7.76Cr 531.57Cr 7.79Cr 55Cr 21Cr 270.26Cr 21Cr 20Cr 869.58Cr | EV / Sales 2024 |
2.43x | EV / Sales 2025 | 2.76x |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -5.13% | ||
| 1 week | -3.90% | ||
| Current month | -10.30% | ||
| 1 month | -2.63% | ||
| 3 months | -12.94% | ||
| 6 months | -12.94% | ||
| Current year | -22.11% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.23 |
| 5 years | 0 | | 1,537.5 |
| 10 years | 0 | | 23,549.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 01/01/2018 | |
Ivy Zhang
DFI | Director of Finance/CFO | 49 | 13/04/2023 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | - | |
Colin Rutherford
BRD | Director/Board Member | 67 | 01/01/2018 |
Kim Kamdar
BRD | Director/Board Member | 58 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/01/24 | Sell | Chief Financial Officer | 104 | 0.0010% | ||
| 21/12/23 | Sell | Director | 10 | 0.0001% | ||
| 13/04/23 | Other | Chief Financial Officer | 13,000 | 0.0107% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.13% | -3.90% | -47.89% | -95.07% | 10L | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,02800Cr | |
| -0.09% | +1.66% | +53.24% | +66.45% | 65TCr | |
| -0.02% | +2.66% | +18.65% | +71.97% | 47TCr | |
| -1.22% | +3.66% | +34.59% | +38.81% | 35TCr | |
| -0.79% | +2.73% | +17.73% | +25.11% | 27TCr | |
| +0.58% | +6.76% | +10.58% | +17.75% | 26TCr | |
| +1.55% | +2.20% | +35.12% | +45.91% | 21TCr | |
| +0.79% | +1.84% | -27.55% | -56.48% | 19TCr | |
| -0.52% | +4.45% | +31.57% | +98.11% | 19TCr | |
| Average | -0.48% | +2.54% | +17.94% | +31.31% | 36.02TCr | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.94Cr 1.69Cr 1.59Cr 1.45Cr 2.71Cr 185.8Cr 2.72Cr 19Cr 7.37Cr 94Cr 7.27Cr 7.11Cr 303.94Cr | 2.02Cr 1.76Cr 1.66Cr 1.51Cr 2.83Cr 193.67Cr 2.84Cr 20Cr 7.68Cr 98Cr 7.58Cr 7.41Cr 316.81Cr |
| Net income | -88.6L -77.26L -72.95L -66.24L -1.24Cr -85Cr -1.25Cr -8.74Cr -3.37Cr -43Cr -3.33Cr -3.25Cr -139.08Cr | 4L 3L 3L 3L 5L 3.75Cr 6L 38.56L 14.88L 1.91Cr 14.69L 14.36L 6.14Cr |
| Net Debt | 4.58Cr 4Cr 3.77Cr 3.43Cr 6.42Cr 439.86Cr 6.45Cr 45Cr 17Cr 223.63Cr 17Cr 17Cr 719.56Cr | 5.44Cr 4.75Cr 4.48Cr 4.07Cr 7.62Cr 522.16Cr 7.65Cr 54Cr 21Cr 265.47Cr 20Cr 20Cr 854.19Cr |
Employees
29
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $0.007400 | -5.13% | 1,00,678 |
| 17/26/17 | $0.007800 | -1.27% | 65,298 |
| 16/26/16 | $0.007900 | +6.76% | 116 |
| 15/26/15 | $0.007400 | -3.90% | 90,015 |
| 14/26/14 | $0.007700 | 0.00% | 45,939 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EVFM Stock
Select your edition
All financial news and data tailored to specific country editions
